{
  "id": "f7135d84bf849bcf934ecc65130c92dd15f4b4b3",
  "title": "NAD+ supplement shows early promise for long COVID fatigue and brain fog",
  "summary": "Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help. Although overall group differences were limited, many participants showed encouraging improvements after taking NR for at least 10 weeks. The findings suggest NAD+ enhancemeâ€¦",
  "canonicalUrl": "https://www.sciencedaily.com/releases/2025/12/251211100629.htm",
  "source": {
    "id": "sciencedaily_health",
    "name": "ScienceDaily - Health & Medicine",
    "url": "https://www.sciencedaily.com/news/health_medicine/",
    "feedUrl": "https://www.sciencedaily.com/rss/health_medicine.xml",
    "country": "US",
    "language": "en"
  },
  "publishedAt": "2025-12-12T03:42:25.000Z",
  "fetchedAt": "2025-12-24T00:05:47.561Z",
  "category": "health",
  "tags": [],
  "image": null,
  "language": "en",
  "storagePath": "data/articles/health/2025/12/12/f7135d84bf849bcf934ecc65130c92dd15f4b4b3.json",
  "contentText": "Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help. Although overall group differences were limited, many participants showed encouraging improvements after taking NR for at least 10 weeks. The findings suggest NAD+ enhancement may offer symptom relief for some individuals.",
  "contentSource": "content"
}
